Andrew Kung, MD, PhD
Pediatric Hematologist-Oncologist & Bone Marrow Transplant Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Pediatric Hematology & Oncology
- Blood & Bone Marrow Transplantation
Request an Appointment
About Me
- Chair, Department of Pediatrics
- Lila Acheson Wallace Chair for Pediatric Research
I am a physician-scientist and Chair of the Department of Pediatrics at Memorial Sloan Kettering. I oversee the clinical, research, and educational missions of the department and MSK Kids. I specialize in caring for my patients using cancer genomics (studying the genetic changes related to cancer), precision medicine (tailoring treatment to the biology of the disease), and stem cell transplantation. In my research, I focus on identifying the causes of pediatric cancers and developing new treatments to benefit children and teens with these diseases.
Read more
Cancer is a frightening diagnosis. It is especially devastating when it occurs in a young person. Because childhood cancers are rare, every child with cancer deserves to be treated in an academic medical center by a team with the experience and knowledge to offer the most-advanced therapies. I feel privileged to lead the dedicated faculty and staff of MSK Kids, which is the largest pediatric oncology program in the United States. We combine the deep expertise of our care teams with the latest scientific approaches to develop the best care plans for our patients while enhancing their well-being.
In my research, I use cutting-edge technologies to pinpoint the molecular roots of cancer and use that new information to improve pediatric cancer treatment. The knowledge we gain when we care for patients also helps drive discovery. My translational research is bidirectional. That means my team takes the latest scientific discoveries from the laboratory and applies them to the care of patients. In turn, how patients fare with their disease in response to treatment tells us what we need to explore in the lab.
As Chair, I am also responsible for advancing MSK’s mission to train the next generation of leaders in pediatric oncology as well as the physician-scientists who will pioneer the therapies of the future. Graduates from our esteemed fellowship program take the advanced knowledge and skills that they learn here to hospitals and industries around the world, spreading MSK’s expertise far beyond our walls to help children everywhere.
In all of these pursuits, my primary focus has been and will always be the care and well-being of our young patients. I feel honored to collaborate with colleagues who share this passion. It is a pleasure to work in an institution so strongly focused on providing exceptional care for children with cancer and blood disorders.
A pediatric hematologist-oncologist is a doctor who treats cancers of the blood in children and adolescents. This doctor is a hematologist (HEE-muh-TAH-loh-jist) who diagnoses and treats blood disorders. They also are an oncologist (cancer doctor).
A bone marrow transplant specialist is a doctor with special training in bone marrow transplants.
My Specialties
- Pediatric Hematology & Oncology
- Blood & Bone Marrow Transplantation
Education
- MD, Stanford University School of Medicine
Residencies
- Pediatrics - Children's Hospital Boston
Awards and Honors
- Castle Connolly: New York Magazine Top Doctors (2016-2017)
- New York's Top Doctors (2016-2017)
- Eugene D. O'Kelly Award, American Cancer Society
- Elected Member, Society for Pediatric Research
- Elected Member, American Society for Clinical Investigation
Fellowships
- Pediatric Hematology/Oncology - Children's Hospital Boston/Dana-Farber Cancer Institute
Board Certifications
- Pediatric Hematology-Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Kung sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Kung’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Andrew Kung discloses the following relationships and financial interests:
-
DarwinHealth Inc.
Professional Services and Activities (Uncompensated) -
Emendo Biotherapeutics
Professional Services and Activities -
Isabl Inc.
Equity; Intellectual Property Rights
-
Karyopharm
Professional Services and Activities -
LabCorp
Intellectual Property Rights
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].